Merck | MRK - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Adidas EUR 646M 550M 2026-03
Adyen EUR 760.51M 127.03M 2025-12
Akzo Nobel EUR 148M 598M 2026-03
Alcon AG USD 240M 24M 2026-03
Amadeus IT EUR 459.7M 133.3M 2026-03
Amarin USD -852K 7.26M 2025-12
AstraZeneca USD 4.81B 894M 2026-06
BASF EUR 1.1B 25M 2026-03
Bayer EUR 321M 2.67B 2026-06
Beiersdorf EUR 408.5M 43.5M 2025-06
Covestro EUR -353M 344M 2025-12
Danone EUR 1.73B 133M 2024-12
Fresenius EUR 535M 42M 2026-06
Fresenius Medical Care EUR 383M 43M 2026-06
Genmab DKK 295M 221M 2026-06
Givaudan CHF 642M 292M 2024-12
GlaxoSmithKline GBP 2.68B 532M 2026-06
GRIFOLS EUR 247M 135M 2026-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Infineon EUR 393M 55M 2026-03
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Linde USD 2.43B 13M 2026-03
Lonza CHF 624M 197M 2024-12
Merck EUR 869M 468M 2026-03
Novartis USD 4.27B 430M 2026-06
Philips EUR 546M 356M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 837M 1.17B 2026-06
UCB EUR 789M 427M 2025-06